开云app官网登录入口网页版-官方正版

#CD8#

65篇内容 | 1841人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1605421, encodeId=74db160542141, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=ARD：白塞病风险变异HLA-B51/ERAP1-Hap10改变人类CD8 T细胞免疫, objectType=article, longId=737273, objectId=0edae372731f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0edae372731f, replyNumber=0, likeNumber=85, createdTime=2022-08-30, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0edae372731f, moduleTitle=ARD：白塞病风险变异HLA-B51/ERAP1-Hap10改变人类CD8 T细胞免疫, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0edae372731f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605420, encodeId=787c16054207a, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Nat Commun：HRS磷酸化驱动PD-L1外泌体分泌并限制CD8+T细胞肿瘤浸润, objectType=article, longId=734443, objectId=eb3fe3444390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb3fe3444390, replyNumber=0, likeNumber=79, createdTime=2022-08-06, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb3fe3444390, moduleTitle=Nat Commun：HRS磷酸化驱动PD-L1外泌体分泌并限制CD8+T细胞肿瘤浸润, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=eb3fe3444390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605419, encodeId=351816054198b, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Front Immunol：pConsensus Peptide (pCons)诱导的狼疮CD8+和CD4+调节性T细胞的细胞和分子表型, objectType=article, longId=294150, objectId=9e0029415006, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e0029415006, replyNumber=0, likeNumber=91, createdTime=2022-01-19, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e0029415006, moduleTitle=Front Immunol：pConsensus Peptide (pCons)诱导的狼疮CD8+和CD4+调节性T细胞的细胞和分子表型, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9e0029415006)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605418, encodeId=df9116054181e, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应, objectType=article, longId=292826, objectId=692329282612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=692329282612, replyNumber=0, likeNumber=80, createdTime=2021-12-29, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=692329282612, moduleTitle=ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=692329282612)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605417, encodeId=e2c7160541ecd, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=阿尔茨海默病候选药物ACD856，新一轮I期研究已经启动, objectType=article, longId=218127, objectId=6f2821812eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2821812eb6, replyNumber=0, likeNumber=76, createdTime=2021-10-06, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2821812eb6, moduleTitle=阿尔茨海默病候选药物ACD856，新一轮I期研究已经启动, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6f2821812eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605416, encodeId=4c831605416b3, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Br J Cancer：CD4、CD8和 FOXP3阳性免疫细胞可作为BRCA1/2相关乳腺癌死亡率的预测标志物, objectType=article, longId=215568, objectId=10ce21556891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10ce21556891, replyNumber=0, likeNumber=79, createdTime=2021-08-12, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10ce21556891, moduleTitle=Br J Cancer：CD4、CD8和 FOXP3阳性免疫细胞可作为BRCA1/2相关乳腺癌死亡率的预测标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=10ce21556891)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605415, encodeId=4345160541595, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=J Gastroenterology: CCL19可以增强CD8+T细胞反应并加速 HBV 清除, objectType=article, longId=214269, objectId=0d2321426943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d2321426943, replyNumber=0, likeNumber=0, createdTime=2021-07-17, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d2321426943, moduleTitle=J Gastroenterology: CCL19可以增强CD8+T细胞反应并加速 HBV 清除, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0d2321426943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605414, encodeId=4ac516054148d, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=DCR: CD4/CD8比率可以作为感染 HIV患者中高度肛门发育不良和肛门癌高风险的依据, objectType=article, longId=213571, objectId=26a92135e197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26a92135e197, replyNumber=0, likeNumber=61, createdTime=2021-07-02, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26a92135e197, moduleTitle=DCR: CD4/CD8比率可以作为感染 HIV患者中高度肛门发育不良和肛门癌高风险的依据, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=26a92135e197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605413, encodeId=993c1605413f9, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Nature Medicine：CD8 + T细胞对感染COVID-19的血液癌患者有益, objectType=article, longId=211708, objectId=9ac5211e08ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ac5211e08ac, replyNumber=0, likeNumber=75, createdTime=2021-05-25, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ac5211e08ac, moduleTitle=Nature Medicine：CD8 + T细胞对感染COVID-19的血液癌患者有益, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9ac5211e08ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605412, encodeId=28a0160541297, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Liver Cancer：探索可预测肝细胞癌对免疫检查点抑制剂响应的耗竭CD8 T细胞标志物, objectType=article, longId=211500, objectId=87b7211500a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87b7211500a5, replyNumber=0, likeNumber=76, createdTime=2021-05-20, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87b7211500a5, moduleTitle=Liver Cancer：探索可预测肝细胞癌对免疫检查点抑制剂响应的耗竭CD8 T细胞标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=87b7211500a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605411, encodeId=88981605411e4, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Nat Commun：循环CD8+T细胞的染色质可及性预测胃癌患者对抗PD-1疗法的应答, objectType=article, longId=207306, objectId=d12f20e30662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12f20e30662, replyNumber=0, likeNumber=105, createdTime=2021-02-20, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12f20e30662, moduleTitle=Nat Commun：循环CD8+T细胞的染色质可及性预测胃癌患者对抗PD-1疗法的应答, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d12f20e30662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605410, encodeId=918816054101f, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Sci Immunol：CD8+ T细胞对新冠病毒感染反应的多重分子特性, objectType=article, longId=206237, objectId=4d9e20623e4d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d9e20623e4d, replyNumber=0, likeNumber=78, createdTime=2021-01-27, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d9e20623e4d, moduleTitle=Sci Immunol：CD8+ T细胞对新冠病毒感染反应的多重分子特性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4d9e20623e4d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605409, encodeId=4dae160540921, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Nat Immunol ：抑制MEK可将CD8+T细胞重编程为抗肿瘤型记忆干细胞, objectType=article, longId=203915, objectId=7c2b203915cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c2b203915cd, replyNumber=0, likeNumber=67, createdTime=2020-12-02, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c2b203915cd, moduleTitle=Nat Immunol ：抑制MEK可将CD8+T细胞重编程为抗肿瘤型记忆干细胞, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7c2b203915cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605408, encodeId=6b18160540864, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=DCR：CD4/CD8比值可以作为HIV 阳性患者高级别肛门异型增生和肛门癌风险的新标志物, objectType=article, longId=203218, objectId=67192032182b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67192032182b, replyNumber=0, likeNumber=64, createdTime=2020-11-11, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67192032182b, moduleTitle=DCR：CD4/CD8比值可以作为HIV 阳性患者高级别肛门异型增生和肛门癌风险的新标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=67192032182b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605407, encodeId=08bb160540e99, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Nature：Vir Biotechnology的增强型单克隆抗体可诱导抗病毒感染的CD8+T细胞应答, objectType=article, longId=201934, objectId=9da620193435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da620193435, replyNumber=0, likeNumber=63, createdTime=2020-10-12, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da620193435, moduleTitle=Nature：Vir Biotechnology的增强型单克隆抗体可诱导抗病毒感染的CD8+T细胞应答, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9da620193435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605406, encodeId=075716054065e, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Blood：维甲酸反应性CD8效应T细胞在胃肠GvHD富含IL-23的组织中选择性扩增, objectType=article, longId=201064, objectId=c86e201064d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c86e201064d5, replyNumber=0, likeNumber=70, createdTime=2020-09-24, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c86e201064d5, moduleTitle=Blood：维甲酸反应性CD8效应T细胞在胃肠GvHD富含IL-23的组织中选择性扩增, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c86e201064d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605405, encodeId=0988160540595, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Blood：JAK/STAT抑制可增强CD8 T细胞对地塞米松诱导性细胞凋亡的敏感性, objectType=article, longId=199167, objectId=fa5b19916e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa5b19916e5c, replyNumber=0, likeNumber=0, createdTime=2020-08-12, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa5b19916e5c, moduleTitle=Blood：JAK/STAT抑制可增强CD8 T细胞对地塞米松诱导性细胞凋亡的敏感性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fa5b19916e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605404, encodeId=3c4d1605404ef, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Blood：JAK/STAT抑制增强CD8 T细胞对地塞米松诱导的细胞凋亡的敏感性, objectType=article, longId=195861, objectId=a97019586128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a97019586128, replyNumber=0, likeNumber=58, createdTime=2020-06-15, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a97019586128, moduleTitle=Blood：JAK/STAT抑制增强CD8 T细胞对地塞米松诱导的细胞凋亡的敏感性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a97019586128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605403, encodeId=c8c1160540331, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Laryngoscope：过敏性鼻炎患者中CD8+ Tregs对外周血单细胞的影响研究 , objectType=article, longId=195704, objectId=65de195e04f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65de195e04f5, replyNumber=0, likeNumber=73, createdTime=2020-06-13, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65de195e04f5, moduleTitle=Laryngoscope：过敏性鼻炎患者中CD8+ Tregs对外周血单细胞的影响研究 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=65de195e04f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1605402, encodeId=e36e160540235, content=<a href='/topic/show?id=94c9436340' target=_blank style='color:#2F92EE;'>#CD8#</a>, objectTitle=Blood：免疫调节剂分子靶点CRBN调控CD8+T细胞激活, objectType=article, longId=195269, objectId=8215195269f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8215195269f7, replyNumber=0, likeNumber=72, createdTime=2020-06-05, rootId=0, userName=ms691033630344116, userId=4bac19388006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8215195269f7, moduleTitle=Blood：免疫调节剂分子靶点CRBN调控CD8+T细胞激活, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8215195269f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

CD8

2020-05-29

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

ARD：白塞病风险变异HLA-B51/ERAP1-Hap10改变人类CD8 T细胞免疫

2022-08-30

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Nat Commun：HRS磷酸化驱动PD-L1外泌体分泌并限制CD8+T细胞肿瘤浸润

2022-08-06

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Front Immunol：pConsensus Peptide (pCons)诱导的狼疮CD8+和CD4+调节性T细胞的细胞和分子表型

2022-01-19

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应

2021-12-29

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

阿尔茨海默病候选药物ACD856，新一轮I期研究已经启动

2021-10-06

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Br J Cancer：CD4、CD8和 FOXP3阳性免疫细胞可作为BRCA1/2相关乳腺癌死亡率的预测标志物

2021-08-12

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

J Gastroenterology: CCL19可以增强CD8+T细胞反应并加速 HBV 清除

2021-07-17

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

DCR: CD4/CD8比率可以作为感染 HIV患者中高度肛门发育不良和肛门癌高风险的依据

2021-07-02

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Nature Medicine：CD8 + T细胞对感染COVID-19的血液癌患者有益

2021-05-25

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Liver Cancer：探索可预测肝细胞癌对免疫检查点抑制剂响应的耗竭CD8 T细胞标志物

2021-05-20

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Nat Commun：循环CD8+T细胞的染色质可及性预测胃癌患者对抗PD-1疗法的应答

2021-02-20

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Sci Immunol：CD8+ T细胞对新冠病毒感染反应的多重分子特性

2021-01-27

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Nat Immunol ：抑制MEK可将CD8+T细胞重编程为抗肿瘤型记忆干细胞

2020-12-02

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

DCR：CD4/CD8比值可以作为HIV 阳性患者高级别肛门异型增生和肛门癌风险的新标志物

2020-11-11

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Nature：Vir Biotechnology的增强型单克隆抗体可诱导抗病毒感染的CD8+T细胞应答

2020-10-12

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Blood：维甲酸反应性CD8效应T细胞在胃肠GvHD富含IL-23的组织中选择性扩增

2020-09-24

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Blood：JAK/STAT抑制可增强CD8 T细胞对地塞米松诱导性细胞凋亡的敏感性

2020-08-12

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Blood：JAK/STAT抑制增强CD8 T细胞对地塞米松诱导的细胞凋亡的敏感性

2020-06-15

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Laryngoscope：过敏性鼻炎患者中CD8+ Tregs对外周血单细胞的影响研究

2020-06-13

ms691033630344116 (审核中...)

前往app查看评论内容

#CD8#

Blood：免疫调节剂分子靶点CRBN调控CD8+T细胞激活

2020-06-05

科室
- - 订阅+
  - 更多科室
工具
服务